Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
Author(s) -
Jicheng Lv,
Hong Zhang,
Muh Geot Wong,
Meg Jardine,
Michelle Hladunewich,
Vivekanand Jha,
Helen Monaghan,
MingHui Zhao,
Sean Barbour,
Heather N. Reich,
Daniel C. Cattran,
Richard J. Glassock,
Adeera Levin,
David C. Wheeler,
Mark Woodward,
Laurent Billot,
Tak Mao Chan,
Zhihong Liu,
David W. Johnson,
Alan Cass,
John Feehally,
Jürgen Floege,
Giuseppe Remuzzi,
Yangfeng Wu,
Rajiv Agarwal,
Hai-Yan Wang,
Vlado Perkovic
Publication year - 2017
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.9362
Subject(s) - medicine , nephropathy , renal function , proteinuria , kidney disease , gastroenterology , randomized controlled trial , methylprednisolone , urology , diabetes mellitus , kidney , endocrinology
Guidelines recommend corticosteroids in patients with IgA nephropathy and persistent proteinuria, but the effects remain uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom